| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| BUY | BUY | BUY | BUY | NEUTRAL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 2.47▼ | 2.45▲ | 2.44▲ | 2.21▲ | 2.14▲ |
| MA10 | 2.46▼ | 2.44▲ | 2.33▲ | 2.16▲ | 2.13▲ |
| MA20 | 2.45▲ | 2.32▲ | 2.22▲ | 2.08▲ | 2.64▼ |
| MA50 | 2.44▲ | 2.20▲ | 2.16▲ | 2.21▲ | 2.34▲ |
| MA100 | 2.34▲ | 2.15▲ | 2.10▲ | 2.80▼ | 9.41▼ |
| MA200 | 2.23▲ | 2.08▲ | 2.09▲ | 2.50▼ | 17.47▼ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | 0.001▲ | 0.009▲ | 0.032▲ | 0.048▲ | 0.015▲ |
| RSI | 55.292▲ | 74.370▲ | 79.241▲ | 64.776▲ | 47.541▼ |
| STOCH | 66.111 | 85.761▲ | 93.277▲ | 74.560 | 31.698 |
| WILL %R | -44.444 | -5.634▲ | -5.263▲ | -4.065▲ | -62.658 |
| CCI | 73.387 | 74.619 | 93.677 | 243.500▲ | -4.253 |
|
Thursday, February 19, 2026 08:43 AM
Cassava Sciences (NASDAQ:SAVA) shares advanced 2.75% on Thursday after the biotech firm disclosed that the U.S. Department of Justice has formally closed its investigation into allegations of research ...
|
|
Thursday, February 19, 2026 05:22 AM
Cassava Sciences, Inc. (NASDAQ: SAVA), is a biotechnology company focused on developing novel, investigational treatments, including simufilam, for central nervous system disorders, such as tuberous ...
|
|
Thursday, February 19, 2026 05:13 AM
Investing.com -- Cassava Sciences (NASDAQ:SAVA) stock rose 2.75% on Thursday after the biotechnology company announced that the U.S. Department of Justice (DOJ) has closed its inquiry into allegations ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 24/02/26 | 2.15 | 2.485 | 2.15 | 2.46 | 2,236,895 |
| 23/02/26 | 2.12 | 2.17 | 2.10 | 2.16 | 441,300 |
| 20/02/26 | 2.16 | 2.17 | 2.085 | 2.13 | 746,910 |
| 19/02/26 | 2.09 | 2.20 | 2.06 | 2.17 | 940,300 |
| 18/02/26 | 2.08 | 2.15 | 2.07 | 2.13 | 280,732 |
| 17/02/26 | 2.10 | 2.1655 | 2.05 | 2.09 | 525,666 |
| 13/02/26 | 2.06 | 2.16 | 2.06 | 2.09 | 467,553 |
| 12/02/26 | 2.15 | 2.17 | 2.04 | 2.05 | 557,699 |
| 11/02/26 | 2.17 | 2.19 | 2.085 | 2.15 | 475,928 |
| 10/02/26 | 2.03 | 2.22 | 2.02 | 2.18 | 948,795 |
|
|
||||
|
|
||||
|
|